Dr. John Paddack

Dr. John Paddack
Dr. Paddack joined Colorado Urology in November 2019 and has been practicing general urology in northern Colorado since 2014. He treats male and female patients for general urologic conditions and has a particular interest in the areas of minimally invasive/robotic surgery for urologic cancers, prostate enlargement, kidney stones, urethral stricture disease, urinary incontinence, and male sexual dysfunction. Dr. Paddack received his Doctor of Medicine degree from Texas Tech University Health Sciences Center, Lubbock, and Amarillo, Texas, where he was inducted into the prestigious Alpha Omega Alpha Medical Honor Society. He then completed both his general surgery internship and urology residency at the University of Arkansas for Medical Sciences in Little Rock, Arkansas. He received his Bachelor of Arts degree from the University of Colorado, where he graduated with distinction. During his residency, Dr. Paddack served as a physician with the African Medical and Research Foundation (AMREF) Urology Outreach in Nairobi, Kenya, and during medical school participated in medical outreach in Mbarara, Uganda in conjunction with Texas Tech University Health Sciences Center Dr. Paddack is certified by the American Board of Urology and is a member of the American Urological Association. Dr. Paddack was born and raised on the Front Range. In his free time, Dr. Paddack enjoys fly fishing, backpacking, running, skiing, mountain biking, traveling, and spending time with his wife and son.
Medical School:

Texas Tech University Health Sciences Center

Residency:

University of Arkansas for Medical Sciences

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only